计算溶液所需的质量、体积或浓度。
提供 ≥98% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
-20°C储存。超低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
KIRA-7, an imidazopyrazine compound, binds the IRE1α kinase ( IC 50 of 110 nM) to allosterically inhibit its RNase activity. KIRA-7 has an anti-fibrotic effect
In Vitro
KIRA-7 can inhibit XBP1 splicing in the alveolar epithelial cell line MLE12. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
KIRA-7 (5 mg/kg; intraperitoneal injection; daily for 14 days; C57BL6 mice) treatment results in decreased spliced XBP1 and ATF4, compared to bleomycin exposed mice treated with vehicle. Likewise, mRNA levels of BiP and CHOP are significantly elevated after Bleomycin exposure, and treatment of Bleomycin-exposed mice with KIRA-7 decreased these levels. mRNA levels of collagen 1A1 and fibronectin are both significantly decreased by KIRA-7 treatment . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: C57BL6 mice (12 weeks of age) with Bleomycin (1.5 units/kg) Dosage: 5 mg/kg Administration: Intraperitoneal injection; daily; for 14 days Result: Resulted in decreased spliced XBP1 and ATF4. Likewise, mRNA levels of BiP and CHOP were significantly decreased.
Form:Solid
IC50& Target:IC50: 110 nM (IRE1α kinase)